Kymera Therapeutics KYMR
$ 44.76
2.87%
Quarterly report 2024-Q3
added 10-31-2024
Kymera Therapeutics Cash Flow 2011-2024 | KYMR
Annual Cash Flow Kymera Therapeutics
2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow |
-103 M | -153 M | -129 M | 88.1 M | 17.9 M | - | - | - | - | - | - | - | - |
Depreciation & Amortization |
3.56 M | 2.98 M | 2.4 M | 1.76 M | 825 K | - | - | - | - | - | - | - | - |
Accounts Payables |
7.08 M | 4.34 M | 4 M | 4.37 M | - | - | - | - | - | - | - | - | - |
Accounts Receivables |
15 M | - | - | - | - | - | - | - | - | - | - | - | - |
Total Inventories |
- | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Quarterly Cash Flow Kymera Therapeutics
2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow |
- | - | -39.6 M | - | - | - | -44 M | - | -114 M | -79.3 M | -40.3 M | - | -90.6 M | -53.3 M | -22.8 M | - | 108 M | -23.5 M | -12.1 M | - | 28.7 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Depreciation & Amortization |
2 M | 1.9 M | 1.46 M | - | 900 K | 900 K | 879 K | - | 800 K | 700 K | 687 K | - | 1.71 M | 1.04 M | 485 K | - | 1.27 M | 776 K | 387 K | - | 464 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Accounts Payables |
6.49 M | 6.51 M | 6.81 M | 7.08 M | 4.98 M | 3.74 M | 6.48 M | 4.34 M | 6.33 M | 2.37 M | 2.57 M | 4 M | 5.03 M | 8.18 M | 8.35 M | 4.37 M | 4.37 M | 4.37 M | 4.37 M | 3.28 M | 3.28 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Accounts Receivables |
- | - | - | 15 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Inventories |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency